General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Investor relations contacts

For all other queries:

Main Switchboard
Switzerland
+41 61 324 11 11

US switchboard

+1 862 778 21 00

For information relating to the registration of your shares, including name or address changes, please contact us by mail or telephone:

Email address: share.registry@novartis.com
Mailing address:

Novartis International AG
Share Registry
WSJ-200.P.75
P.O.Box
CH-4002 Basel / Switzerland

+41 61 324 72 04
+41 61 324 32 44

Stock chart